Target Name: MIR494
NCBI ID: G574452
Review Report on MIR494 Target / Biomarker Content of Review Report on MIR494 Target / Biomarker
MIR494
Other Name(s): MIRN494 | hsa-miR-494-3p | Hsa-mir-494 | MicroRNA 494 | microRNA 494 | hsa-mir-494 | hsa-miR-494-5p | mir-494

MIR494: A Potential Drug Target and Biomarker for Obesity

Obesity is a significant public health issue, with an estimated 285 million adults worldwide categorized as obese or overweight. The increasing prevalence of obesity is associated with an increased risk of various chronic diseases, including cardiovascular disease, diabetes, and certain cancers. As such, identifying potential drug targets and biomarkers for obesity is of great importance for the development of effective therapies. In this article, we will explore MIR494, a potential drug target and biomarker for obesity.

MIR494 is a non-coding RNA molecule that is expressed in various tissues and organs, including fat cells, muscle cells, and the brain. It has been shown to play a critical role in the regulation of energy metabolism and has been implicated in the development and maintenance of obesity. MIR494 has been shown to promote the expression of genes involved in energy metabolism, such as those involved in lipid metabolism, and has been shown to inhibit the expression of genes involved in energy expenditure, such as those involved in muscle activity.

In addition to its role in energy metabolism, MIR494 has also been shown to play a critical role in the regulation of gene expression and has been implicated in the development of obesity-related diseases. For example, MIR494 has been shown to promote the expression of genes involved in the production of fructose, a sugar that can contribute to weight gain. Additionally, MIR494 has been shown to promote the expression of genes involved in the production of leptin, a hormone that helps regulate body weight.

MIR494 has also been shown to play a critical role in the development of obesity-related diseases, including obesity and type 2 diabetes. For example, MIR494 has been shown to be involved in the regulation of insulin sensitivity and has been shown to contribute to the development of insulin resistance, a condition that is associated with the development of type 2 diabetes. Additionally, MIR494 has been shown to be involved in the regulation of inflammation and has been shown to contribute to the development of obesity-related diseases, including obesity and type 2 diabetes.

In conclusion, MIR494 is a potential drug target and biomarker for obesity. Its role in energy metabolism, gene regulation, and the regulation of obesity-related diseases makes it an attractive target for drug development. Further research is needed to fully understand the role of MIR494 in obesity and to develop effective therapies that target it.

Protein Name: MicroRNA 494

The "MIR494 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR494 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR495 | MIR496 | MIR497 | MIR497HG | MIR498 | MIR4999 | MIR499A | MIR499B | MIR5000 | MIR5001 | MIR5002 | MIR5003 | MIR5004 | MIR5006 | MIR5007 | MIR5008 | MIR5009 | MIR500A | MIR500B | MIR501 | MIR5010 | MIR5011 | MIR502 | MIR503 | MIR503HG | MIR504 | MIR5047 | MIR505 | MIR506 | MIR507 | MIR508 | MIR5088 | MIR5089 | MIR509-1 | MIR509-2 | MIR509-3 | MIR5090 | MIR5091 | MIR5092 | MIR5093 | MIR5094 | MIR510 | MIR5100 | MIR511 | MIR511-2 | MIR512-1 | MIR512-2 | MIR513A1 | MIR513A2 | MIR513B | MIR513C | MIR514A1 | MIR514A2 | MIR514A3 | MIR514B | MIR515-1 | MIR515-2 | MIR516A1 | MIR516A2 | MIR516B1 | MIR516B2 | MIR517A | MIR517B | MIR517C | MIR5186 | MIR5187 | MIR5188 | MIR5189 | MIR518A1 | MIR518A2 | MIR518B | MIR518C | MIR518D | MIR518E | MIR518F | MIR5190 | MIR5191 | MIR5192 | MIR5193 | MIR5194 | MIR5195 | MIR5196 | MIR5197 | MIR519A1 | MIR519A2 | MIR519B | MIR519C | MIR519D | MIR519E | MIR520A | MIR520B | MIR520C | MIR520D | MIR520E | MIR520F | MIR520G | MIR520H | MIR521-1 | MIR521-2 | MIR522